Annovis Bio Says US FDA Approved Use of Neurodegeneration Drug Buntanetap in Crystalline Form
Annovis Bio Says US FDA Approved Use of Neurodegeneration Drug Buntanetap in Crystalline Form
Annovis Bio表示美國FDA已批准使用晶態布替奈治療神經退化症。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊